- PR Newswire
Ganapathi Pulipaka, PhD, has been Inducted into the Prestigious Marquis Who's Who Biographical Registry
Dr. Ganapathi Pulipaka has been inducted into Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
- Reuters
Pakistan drug firm to import potential COVID-19 treatment from Bangladesh
A pharmaceutical company in Pakistan plans to import the antiviral drug remdesivir, which has shown promise in treating coronavirus patients, from neighbouring Bangladesh, it said in a stock exchange filing on Friday. The announcement by Searle Company Limited came a day after 56 virus deaths recorded by the south Asian nation, its highest toll in a single day. The firm said it had entered into an exclusive licensing and marketing agreement with Bangladesh's Beximco Pharmaceuticals , the first company in the world to introduce the generic variant of the drug.
- Reuters
EU's Vestager denies making Lufthansa bailout more difficult
EU antitrust chief Margrethe Vestager denied on Friday that she was putting hurdles in the way of Lufthansa's $10 billion government rescue, saying companies getting big capital injections from the state have to offset their competitive advantage. Vestager wants Lufthansa to permanently give up some take-off and landing slots at Frankfurt and Munich airports, where it commands a two-thirds market share, in return for giving the green light to the German government taking a 20% stake in the airline. Lufthansa's board, however, has rejected her demands.
- Reuters
Wall Street Weekahead: Investors eye consumer discretionary stocks as U.S. reopens
Investors are taking a closer look at the market's consumer discretionary companies as a reopening U.S. economy fuels hopes of a turnaround for some of the sector's hardest-hit names. Many companies in the sector have been battered by the country-wide coronavirus-fueled lockdowns that have weighed on growth and damaged retail spending over the last several months, though the stocks of a few, like Amazon, have soared. A gradual lifting of lockdowns in some states has stirred hopes for a bounce back for the retailers that make up much of the sector.
- Financial Times
Renault to slash about 15,000 jobs in €2bn cost-cutting plan
Renault plans to cut about 15,000 jobs, shrink production and restructure some of its French factories as the carmaker seeks to slash €2bn in costs amid falling demand and the aftermath of the 2018 arrest of Carlos Ghosn. After recording its first loss in a decade last year and with sales slumping, Renault is trying to achieve more than €2bn in savings over the next three years while cutting global production capacity from 4m vehicles in 2019 to 3.3m by 2024. “The slowdown of the automotive market combined with ever stricter regulations over the past three years partly contributed to our performance decline, and the Covid crisis has only aggravated an already existing situation and led us to take tough decisions,” said Renault’s interim chief executive Clotilde Delbos.
- Simply Wall St.
Read This Before Selling Arizona Silver Exploration Inc. (CVE:AZS) Shares
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
- Reuters
Oil analysts see prices edging up but still capped below $40/bbl: Reuters poll
The survey of 43 analysts forecast Brent crude would average $37.58 a barrel in 2020, about 5% above April's $35.84 consensus, but still lower than the $42.37 average so far this year. Global benchmark Brent hit a 21-year low of $15.98 a barrel last month as demand collapsed amid the coronavirus pandemic.
- PR Newswire
HSBC Holdings plc Announces Total Available Amount For Tender Offers
On May 28, 2020, HSBC Holdings plc (the "Company," "we" or "us") announced the launch of five separate offers to purchase for cash any and all of the outstanding series of notes listed in the table below. We refer to the outstanding notes listed in the table below collectively as the "Notes" and separately as a "series" of Notes. We refer to each offer to purchase a series of Notes as an "Offer", and collectively as the "Offers."
- Reuters
Focus: Pandemic saps union clout as talks loom with Chile copper miners
Chile's powerful copper unions are headed into contract talks with a hand weakened by the coronavirus pandemic, giving an edge to miners like Codelco, Glencore and Antofagasta in negotiations that could influence wages and benefits for years. Chile's generally well-paid copper mine workers argue they should be adequately compensated for working in a riskier environment to keep pits open during the pandemic. Union leaders said it would be harder to achieve wage hikes, bonuses and benefit boosts now that the pandemic has swept through the global copper market and hit profits for miners in Chile, the world's top producer.
- Bloomberg
Iron Ore Powers Past $100 as Supply Woes Meet Robust Demand
(Bloomberg) -- Iron ore surged past $100 a ton as supply woes in Brazil coincide with sustained, robust demand in top steel producer China.Benchmark spot prices climbed to $101.05 on Friday as Brazil, the world’s second-largest exporter, saw a surge in coronavirus infections, stoking worries that the pandemic may curb local supply. In April, miner Vale SA cut its annual shipment guidance on bad weather and the virus’s impact on operations. Meanwhile, port stockpiles of iron ore in China have continued to decline.The industrial staple has prospered in 2020 even as the coronavirus pandemic hammered industrial activity in many economies, although Bloomberg Intelligence has been among observers warning that market may flip to a surplus in the second half. In addition to Vale, the higher prices will bolster returns at BHP Group, Rio Tinto Group and Fortescue Metals Group Ltd.The early resumption of industrial operations in China has fueled a recovery in downstream activity and steel mills continue to increase output, China International Capital Corp. analysts including Ma Kai wrote in a note. “Iron ore will fundamentally maintain a tight balance this year,” with supply gradually recovering from the third quarter, they said.Benchmark spot prices are at the highest since August. Futures in Singapore were at $97, heading for their biggest ever monthly gain. On the Dalian Commodity Exchange, futures have rallied 23% in May.Credit Suisse Group AG recently estimated that the market is now at “peak tightness,” a condition that will probably persist until July. Bloomberg Intelligence expects a 34-million-ton surplus in the second half on higher supply and stagnating demand, flipping from a 25-million-ton deficit in the first half. That’s throwing a spotlight on whether the price gains are sustainable.“There remain doubts” as to the strength of the rally over the next one to three months, said Hui Heng Tan, analyst at Marex Spectron Group. A pickup in supply in Australia and Brazil is expected to gather pace, although disruptions in the South American country will be a factor to watch in the second half, he said. That increase in volumes could potentially coincide with when China exits its peak construction period with elevated steel stockpiles, he said.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- Business Wire
AVEO Oncology Announces Phase 1b/2 DEDUCTIVE Study of FOTIVDA® (tivozanib) in Combination with IMFINZI® (durvalumab) in Previously Untreated Metastatic Hepatocellular Carcinoma Advances to Phase 2
AVEO Oncology (NASDAQ: AVEO) today announced that the Phase 1b/2 DEDUCTIVE clinical trial evaluating FOTIVDA® (tivozanib), the Company’s once-daily, potent and selective next-generation vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI), in combination with IMFINZI® (durvalumab), AstraZeneca’s (LSE/STO/NYSE: AZN) human monoclonal antibody directed against programmed death-ligand 1 (PD-L1), in patients with hepatocellular carcinoma (HCC) who have not received prior systemic therapy, has demonstrated that the combination can be administered safely and the study has successfully progressed to the Phase 2 portion of the trial.
- Simply Wall St.
NanoXplore, Inc. (CVE:GRA) Just Reported Earnings, And Analysts Cut Their Target Price
The quarterly results for NanoXplore, Inc. (CVE:GRA) were released last week, making it a good time to revisit its...
- Investor's Business Daily
Dow Jones Futures: Coronavirus Stock Market Rally Awaits Trump China News; Twitter Feud Escalates; Salesforce, Zscaler Lead Earnings Movers
Futures: The coronavirus stock market rally awaits President Trump's press conference on China, as his feud with Twitter escalates. Salesforce and Zscaler are key earnings movers.
- Motley Fool
Got $3,000? Here Are 3 Great Biotech Stocks to Buy Right Now
While the broader market indexes are still down year to date despite strong rebounds in recent weeks, the major biotech exchange-traded funds (ETFs) are in solid positive territory for the year. Granted, not all biotech stocks are doing well. If you've got $3,000 to invest, here are three great biotech stocks to buy right now that have what it takes for long-term success.
- Motley Fool
Decoding the Stock Market: The Vocabulary of Volatility
When the stock market is making large up and down moves on a regular basis, you may hear that we're in a "volatile" market, but what does that mean? While the word volatility is often used to describe general stock market action, or big movements in a certain stock, there's quite a bit more to the concept of volatility than that. A more specific definition of the word volatility when it comes to the stock market is how large the price movements of a stock or index have been (or are expected to be).
- Business Wire
Global Liquid Sugar Market Analysis 2020-2025 - Increased Usage of Liquid Sugar in Bakery and Confectionery Products - ResearchAndMarkets.com
The "Liquid Sugar Market - Growth, Trends, and Forecast (2020 - 2025)?" report has been added to ResearchAndMarkets.com's offering.
- Thomson Reuters StreetEvents
Edited Transcript of LXS.DE earnings conference call or presentation 6-May-20 8:00am GMT
Q1 2020 LANXESS AG Earnings Press Conference
- MarketWatch
Here’s what the Fed will do next, according to a Goldman Sachs economist
David Mericle, an economist at Goldman Sachs, outlined what he thinks is coming from the Federal Reserve.
- Business Wire
Mastercard Launches Recovery Insights Initiative to Inform Business and Government Economic Response Efforts
Mastercard launches Recovery Insights to provide businesses and governments some certainty today and support data-driven decision-making for tomorrow.
- Variety
‘I’m No Longer Here’: Film Review
In Mexico, Monterrey has a notorious gang problem, often linked to street violence and drugs in a city where cartels pose a national threat, but 17-year-old Ulises and his friends aren’t part of it. Technically, their little group is also a gang — they call themselves “Los Terkos,” dress alike in baggy clothes and sport […]
- Fox Business
Hospitals' financial losses, layoffs from coronavirus are a disaster
Before the next pandemic hits, we’ll need a far better strategy. Here are three suggestions.
- Business Wire
Bruker Introduces Breakthrough MALDI-2 Source on timsTOF fleX, and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF
Bruker Introduces Breakthrough MALDI-2 Source on timsTOF fleX and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF.
- CNW Group
TVI Pacific Announces Reliance on Relief from Filing and Delivery Requirements for Annual Financial Statements and Associated MD&A and Interim Q1 2020 Financial Statements and Associated MD&A
TVI Pacific Announces Reliance on Relief from Filing and Delivery Requirements for Annual Financial Statements and Associated MD&A and Interim Q1 2020 Financial Statements and Associated MD&A
- PR Newswire
Oncolytics Biotech® Presents Clinical Proof-of-Concept Data in Multiple Myeloma at the ASCO Virtual Annual Meeting
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced the publication of an electronic-poster (ePoster) with clinical proof-of-concept data from the Company's phase 1b study in carfilzomib-refractory multiple myeloma patients treated with pelareorep in combination with carfilzomib (Kyprolis®). Data presented in the ePoster demonstrates that the pelareorep-carfilzomib combination treatment results in selective replication of pelareorep in cancer cells and beneficial induction of an inflamed tumor environment associated with clinical responses. The ePoster was published this morning and will be presented this weekend as part of the American Society of Clinical Oncology (ASCO) Virtual Annual Meeting.
- Business Wire
Tangen Biosciences and LabWare Formed an Exclusive Partnership for Point-of-Care COVID-19 Molecular Test and Real-time Data Reporting
Tangen Biosciences and LabWare Formed an Exclusive Partnership for Point-of-Care COVID-19 Molecular Test and Real-time Data Reporting
